BJA FY25 Comprehensive Opioid, Stimulant, and Substance Use, Site-Based Program
ID: 358206Type: Posted
Overview

Buyer

Bureau of Justice Assistance (USDOJ-OJP-BJA)

Award Range

$0 - $7M

Eligible Applicants

Nonfederally Recognized Native American Tribal Organizations

Funding Category

Law, Justice and Legal Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358206

Additional Information

https://bja.ojp.gov/funding/opportunities/o-bja-2025-172334
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jan 14, 2025, 12:00 AM UTC
  4. 4
    Due Mar 12, 2025, 12:00 AM UTC
Description

The Bureau of Justice Assistance is offering a federal grant opportunity titled "BJA FY25 Comprehensive Opioid, Stimulant, and Substance Use, Site-Based Program" aimed at supporting state, territorial, local, and tribal governments in their efforts to reduce overdose deaths and the impact of substance use disorders within their communities. This program seeks to enhance access to prevention services, improve harm reduction initiatives, expand treatment and recovery services, and develop additional resources within the community and justice system, thereby aligning with the Department of Justice's mission to increase treatment access for individuals involved in the criminal justice system. Eligible applicants include nonfederally recognized Native American Tribal Organizations, with a total funding ceiling of $7 million and an expected 63 awards to be made. Interested parties should note that the application deadline is March 12, 2025, and can reach out to grants@ncjrs.gov for technical assistance or further inquiries.

Point(s) of Contact
grants@ncjrs.gov
Files
No associated files provided.
Similar Opportunities
Rural Opioid Technical Assistance Regional Centers
Substance Abuse and Mental Health Services Adminis
The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Rural Opioid Technical Assistance Regional Centers." This program aims to establish regional centers of excellence that will provide training and technical assistance to combat opioid and stimulant misuse in rural communities. The initiative is crucial for addressing the growing health crisis related to substance abuse in these areas, with an estimated total program funding of $7,150,000 and the expectation of awarding 11 grants. Interested applicants, including public or nonprofit entities, states, Indian tribes, and health facilities, can reach out to Twyla Adams at (240) 276-1576 or via email at twyla.adams@samhsa.hhs.gov for further information. The opportunity is currently posted, with an estimated synopsis posting date of May 1, 2025.
OVW Fiscal Year 2025 Special Tribal Criminal Jurisdiction (STCJ) Grant Program
Office on Violence Against Women
The Office on Violence Against Women (OVW) is offering the Fiscal Year 2025 Special Tribal Criminal Jurisdiction (STCJ) Grant Program to support federally recognized Native American Tribal Governments in exercising jurisdiction over non-Indians who commit specific crimes within their boundaries. This grant program aims to empower Tribal governments to address "covered crimes," which include various forms of violence such as domestic violence, sexual violence, and stalking, thereby enhancing the safety and justice within Tribal communities. With an estimated total program funding of $8 million, the OVW anticipates awarding six grants, with individual awards ranging from $1 million to $1.5 million. Interested applicants must submit their proposals by April 29, 2025, and can reach out to OVW at OVW.TribalJurisdiction@usdoj.gov for further assistance.
Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
OVC FY25 Tribal Victim Services Set-Aside Formula Program
Office for Victims of Crime
The Office for Victims of Crime (OVC) is offering the FY25 Tribal Victim Services Set-Aside Formula Program, a federal grant aimed at supporting services for crime victims in American Indian and Alaska Native communities. This program allocates funding to participating Tribes through a discretionary administrative formula based on Population Certifications submitted by federally recognized Indian Tribes and Alaska Native Claims Settlement Act Regional Corporations. With an estimated total program funding of $49 million and an expected 220 awards, the initiative seeks to enhance and expand victim services in Tribal communities, addressing the diverse needs of crime victims. Interested applicants must submit their Population Certifications by January 17, 2024, and can reach out to the OVC at ovctribalsetaside@ojp.usdoj.gov for assistance, with applications due by May 9, 2025.
Tribal Behavioral Health
Substance Abuse and Mental Health Services Adminis
The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Tribal Behavioral Health," aimed at preventing and reducing suicidal behavior and substance use among American Indian/Alaska Native (AI/AN) youth, up to age 24. This program seeks to build a supportive network of systems, services, and partnerships to promote mental health and address the impacts of trauma within these communities. With an estimated total program funding of $7,861,000 and the expectation of awarding 31 grants, eligibility is limited to federally recognized AI/AN tribes, tribal organizations, Urban Indian Organizations, or consortia of tribes or tribal organizations. Interested applicants can reach out to Kathleen Burkhart at kathleen.burkhart@samsha.hhs.gov or (240) 276-1313 for further information, with the synopsis expected to be posted on November 15, 2024.
Rural Communities Opioid Response Program-Stimulant Support
Health Resources and Services Administration
The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled "Rural Communities Opioid Response Program-Stimulant Support," aimed at enhancing access to prevention, treatment, and recovery services for stimulant use disorder in rural areas. This program seeks to reduce the prevalence and impact of stimulant use disorder, with a focus on coordinated and comprehensive service delivery. The estimated total program funding is $20 million, with an award ceiling of $500,000 and approximately 10 awards expected. Interested applicants, particularly small businesses, can reach out to Sarah O'Donnell at 301-443-0298 or via email at ruralopioidresponse@hrsa.gov for further information. Key deadlines include an estimated synopsis post date of December 16, 2024, and a close date of March 19, 2025, with project start anticipated on September 1, 2025.
First Responders – Comprehensive Addiction and Recovery Act
Substance Abuse and Mental Health Services Adminis
The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "First Responders – Comprehensive Addiction and Recovery Act," aimed at supporting first responders and key community members in administering emergency treatments for opioid overdoses. This program is designed to enhance the capacity of eligible entities, including states, local governments, and tribal organizations, to utilize approved drugs or devices for the rapid reversal of opioid overdoses, addressing a critical public health issue. With an estimated total program funding of $5.1 million and an expected 12 awards, interested applicants can reach out to Shannon Hastings at (240) 276-1869 or via email at DTPFRCARA@samhsa.hhs.gov for further information. The synopsis for this opportunity is anticipated to be posted on November 15, 2024, with no cost-sharing or matching requirements.
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications that support a diverse range of preclinical and clinical projects, with the goal of advancing medication studies toward FDA approval, emphasizing the importance of innovative approaches to drug misuse and addiction treatment. Eligible applicants include a variety of institutions, such as higher education entities and community organizations, with funding available up to $5 million per year for projects lasting up to three years. Interested parties can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by August 11, 2025.
Behavioral Health Partnership for Early Diversion of Adults and Youth
Substance Abuse and Mental Health Services Adminis
The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Behavioral Health Partnership for Early Diversion of Adults and Youth." This program aims to establish or expand initiatives that divert individuals with mental illness or co-occurring disorders from the criminal or juvenile justice systems to community-based mental health and substance use disorder services prior to arrest and booking. Such programs are crucial for enhancing public health and safety by providing necessary support to vulnerable populations. The estimated total program funding is $2 million, with approximately six awards expected, and interested applicants can reach out to Roxanne Castenada at roxanne.castenada@samhsa.hhs.gov or (240) 276-1917 for further information. The synopsis is anticipated to be posted on December 16, 2024, for the fiscal year 2025.
Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity for the development of medications aimed at preventing and treating substance use disorders (SUDs) and overdose. This initiative is structured into two phases: the UG3 phase focuses on achieving specific milestones within a two-year period, while the UH3 phase extends support for an additional three years for projects that successfully meet the UG3 milestones. Given the urgent need for effective treatments in light of rising overdose deaths, particularly from synthetic opioids and stimulants, this funding opportunity emphasizes innovative research methodologies and the effective application of existing medications. Interested applicants can seek funding of up to $3 million annually for a maximum of five years, with applications due by August 11, 2025. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-329.html.